Welcome to the latest update on Celldex Therapeutics, Inc. (CLDX) insider trading activities. Investors are closely watching the recent moves by company executives.
Insider: MARTIN SAMUEL BATES
Action:
Shares: 4,817
Value: $50,000
Reported on: 2026-01-02
This page is an informational research aid, not investment advice. Insider and institutional ownership data can lag official filings, so confirm material decisions with SEC filings, company releases, and your own brokerage tools.
Tracking insider transactions like those of Celldex Therapeutics, Inc. provides crucial insights. When insiders buy, it often signals confidence. This page is automatically generated to track the latest filings for CLDX to help global investors make informed decisions.
Use this tracker as a starting point for research: compare insider activity with earnings dates, valuation, sector rotation, analyst revisions, and market liquidity before drawing conclusions.